WCAS — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Avetta operates a platform that connects businesses with suppliers, focusing on compliance, safety, and performance verification across supply chains.
B2B MarketplacesEnterprise SoftwareLogistics & Supply ChainSaaS
Co-investorsGolub GrowthNorwest Venture Partners
Kiniciti is a platform company that operates cell and gene therapy-focused life science businesses, including Cellistic for iPSC-based manufacturing technologies and Ncardia for human iPSC products and drug discovery services.
BiotechDeep TechHealthtechMedical Devices
Geoffrey Glass(Founding CEO)in
Co-investorsBIOSPRING PARTNERSWelsh, Carson, Anderson & Stowe
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.